Cristin-resultat-ID: 1921224
Sist endret: 18. februar 2022, 12:37
NVI-rapporteringsår: 2021
Resultat
Vitenskapelig artikkel
2021

Using process indicators to monitor documentation of patient-centred variables in an integrated oncology and palliative care pathway—results from a cluster randomized trial

Bidragsytere:
  • Marianne Jensen Hjermstad
  • Julian Hamfjord
  • Nina Kathrine Aass
  • Olav Dajani
  • Tonje Lundeby
  • Torunn Elin Wester
  • mfl.

Tidsskrift

Cancers
ISSN 2072-6694
e-ISSN 2072-6694
NVI-nivå 1

Om resultatet

Vitenskapelig artikkel
Publiseringsår: 2021
Volum: 13
Hefte: 9
Sider: 1 - 16
Open Access

Importkilder

Scopus-ID: 2-s2.0-85104944719

Beskrivelse Beskrivelse

Tittel

Using process indicators to monitor documentation of patient-centred variables in an integrated oncology and palliative care pathway—results from a cluster randomized trial

Sammendrag

Background. Despite robust evidence from randomized controlled trials (RCTs) demonstrating clinical and patient-reported benefits of integrated oncology and palliative care, the tumour-centred focus is predominant. This single–centre process evaluation monitors documentation of required patient-centred variables during an RCT. Methods. Performance status, patient self-reported symptoms, weight and summaries to general practitioners were assessed from June 2017 to July 2020 in three consultation types: first oncological after study inclusion and palliative and oncological consultations during chemotherapy. Descriptive statistics were used to monitor if the pre-defined program fulfilment of ≥85% documentation was reached. Results. 435 consultations were monitored in 76 patients; 60.5% males, 86.8% with GI cancers; 76 (17.5%) were from the first oncological consultations, 87 (20.0%) and 272 (62.5%) from palliative or subsequent oncological consultations. Program fulfilment differed across consultation types with 94.8% in the palliative consultations (83.3–100%), relative to 65.8% (62.5–75.0%) and 69.2% (57.0–84.3%) for first and subsequent oncological consultations over time, respectively. Use of self-reported symptoms was consistently lower in the oncological consultations. Conclusions. The documentation level of required core variables was not satisfactory, notwithstanding their high clinical relevance and continuous reminders during study. Pre-trial optimization strategies are paramount to promote integration and reduce professional and personal barriers towards a more patient-centred focus.

Bidragsytere

Marianne Jensen Hjermstad

  • Tilknyttet:
    Forfatter
    ved Avdeling for kreftbehandling ved Universitetet i Oslo
  • Tilknyttet:
    Forfatter
    ved Avdeling for kreftbehandling ved Oslo universitetssykehus HF

Julian Hamfjord

  • Tilknyttet:
    Forfatter
    ved Avdeling for kreftbehandling ved Oslo universitetssykehus HF
  • Tilknyttet:
    Forfatter
    ved Det medisinske fakultet ved Universitetet i Oslo

Nina Kathrine Aass

  • Tilknyttet:
    Forfatter
    ved Avdeling for kreftbehandling ved Universitetet i Oslo
  • Tilknyttet:
    Forfatter
    ved Avdeling for kreftbehandling ved Oslo universitetssykehus HF

Olav Dajani

  • Tilknyttet:
    Forfatter
    ved Avdeling for kreftbehandling ved Universitetet i Oslo
  • Tilknyttet:
    Forfatter
    ved Avdeling for kreftbehandling ved Oslo universitetssykehus HF

Tonje Lundeby

  • Tilknyttet:
    Forfatter
    ved Avdeling for kreftbehandling ved Universitetet i Oslo
  • Tilknyttet:
    Forfatter
    ved Avdeling for kreftbehandling ved Oslo universitetssykehus HF
1 - 5 av 7 | Neste | Siste »